ARTICLES BY THIS AUTHOR
- 12/29/2020
Zeposia: new oral treatment for relapsing-remitting multiple sclerosis
Third oral sphingosine 1-phosphate receptor modulator to be marketed for MS in Canada. - 12/28/2020
Favipiravir oral tablets being considered by Health Canada as a COVID-19 treatment
Third drug to be filed for treatment of COVID-19 under Interim Order, following IV remdesivir and IV bamlanivimab. - 12/22/2020
The things that didn’t change in 2020
As we mourn the loss of lives and livelihoods, so much is different. But 2020 didn't change absolutely everything. This past year also saw an outdated healthcare system continuing to rely on the fax machine, even for urgent matters. Some clinics continued to ask for their form to be used for all consultation requests, even if all of the information was included in the original request letter. And doctors continued to receive all manner of medico-legal paperwork.